Core Laboratories Q2 2024 Adj EPS $0.22 Beats $0.21 Estimate, Sales $130.577M Miss $132.170M Estimate
Core Laboratories Q2 2024 Adj EPS $0.22 Beats $0.21 Estimate, Sales $130.577M Miss $132.170M Estimate
core laboratories 2024年Q2調整每股收益爲0.22美元，超過了0.21美元的估計，銷售額爲13057.7萬美元，未達到13217萬美元的估計。
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.21 by 4.76 percent. This is a 4.76 percent increase over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $130.577 million which missed the analyst consensus estimate of $132.170 million by 1.21 percent. This is a 2.11 percent increase over sales of $127.881 million the same period last year.
Core Laboratories（紐交所：CLB）報告季度每股收益爲0.22美元，超過分析師一致預期的0.21美元，增長了4.76％。 這是比去年同期每股收益0.21美元增長4.76％。 該公司季度銷售額爲13057.7萬美元，較分析師一致預期的13217萬美元低1.21％。 這是與去年同期銷售額12788.1萬美元相比增長了2.11％。